Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BlackRock Inc.BLK · Entity 12961 | Director | June 28, 2024 | July 02, 2024 |
| BlackRock, Inc.BLK · Entity 2850 | Director | September 30, 2026 | October 02, 2026 |
| Zoetis Inc.ZTS · Entity 679 | Director · Chief Executive Officer | October 09, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BlackRock Inc.
Report date June 28, 2024 · Filed July 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares Of Common Stock (par Value $0.01 Per Share)SEC Table I · non-derivative | Direct | 1,360 |
Reported balance
After 2024-06-28 transaction · row 1
1 source rowRow 1 · 2024-06-28 · Grant · Acquired 40 · Balance 1,360 F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024.
BlackRock, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares Of Common Stock (par Value $0.01 Per Share)SEC Table I · non-derivative | Direct | 2,092 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 30 · Balance 2,092 F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026.
Zoetis Inc.
Report date October 09, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitSEC Table II · derivative / convertible security | Direct | 66,915.04 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 720.1441 · Balance 66,915.04 F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. |
Filing footnotes · ownership attribution and instrument terms
F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date October 31, 2012 · Filed November 01, 2012
Section 16 reporting ended · disclosed 2012-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 6,375 |
Reported balance
After 2012-10-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2012-10-31 · Grant · Acquired 39 · Balance 6,375 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 11,994 | $203.39 | $2,439,459.66 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,430 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.01 to $203.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 12,000 | $30.89 | $370,680.00 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:14 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 261.4323 | $61.79 | $16,153.90 |
DisclosureSEC source: 0001555280-21-000275 · wf-form4_162681923897198.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,573.9527 Underlying: Common Stock · 80.8989 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,263 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 39,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,900 | $175.94 | $862,106.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,424 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.70 to $176.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 9,600 | $175.20 | $1,681,920.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,324 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.69 to $175.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 12,000 | $30.89 | $370,680.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 21:39 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 1,516.178 | $49.95 | $75,733.09 |
DisclosureSEC source: 0001555280-21-000201 · wf-form4_161834993855582.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,312.5204 Underlying: Common Stock · 473.776 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:29 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 1,211.4577 | $49.51 | $59,979.27 |
DisclosureSEC source: 0001555280-21-000182 · wf-form4_161722612629369.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,796.3424 Underlying: Common Stock · 378.6809 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:19 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000152 · wf-form4_161463356771979.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,263 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 51,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:19 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 3,282 | $158.83 | $521,280.06 |
DisclosureSEC source: 0001555280-21-000152 · wf-form4_161463356771979.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,924 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.60 to $159.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:19 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 13,145 | $158.25 | $2,080,196.25 |
DisclosureSEC source: 0001555280-21-000152 · wf-form4_161463356771979.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,206 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.59 to $158.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:19 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 12,000 | $30.89 | $370,680.00 |
DisclosureSEC source: 0001555280-21-000152 · wf-form4_161463356771979.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 10,145.4088 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 6 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,145.4088 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 6,948.8824 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,813.5715 Underlying: Common Stock · 6,948.8824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 4,095 | $166.71 | $682,677.45 |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,351 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 10,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 2,521 | $166.71 | $420,275.91 |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,301 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:19 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 61,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000091 · wf-form4_161317195897395.xml · derivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,263 Underlying: Common Stock · 61,078 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:19 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 14,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000091 · wf-form4_161317195897395.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,762.4539 Underlying: Common Stock · 14,381 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 6,948.8824 RSUs will vest on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:11 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 10,145.4088 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000040 · wf-form4_161308509096630.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,145.4088 Underlying: Common Stock · 10,145.4088 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 22:57 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 294.0375 | $50.36 | $14,807.73 |
DisclosureSEC source: 0001555280-21-000022 · wf-form4_161118342849042.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,584.8847 Underlying: Common Stock · 91.6547 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 21:42 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000322 · wf-form4_160634052477128.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,185 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 6,500 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 21:42 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 3,375 | $162.32 | $547,830.00 |
DisclosureSEC source: 0001555280-20-000322 · wf-form4_160634052477128.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.86 to $162.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 21:42 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 7,125 | $161.12 | $1,147,980.00 |
DisclosureSEC source: 0001555280-20-000322 · wf-form4_160634052477128.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,249 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.81 to $161.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 21:42 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,500 | $30.89 | $200,785.00 |
DisclosureSEC source: 0001555280-20-000322 · wf-form4_160634052477128.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:42 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 246.7886 | $51.43 | $12,692.34 |
DisclosureSEC source: 0001555280-20-000307 · wf-form4_160262530696690.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,290.8472 Underlying: Common Stock · 76.7233 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,685 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 6,500 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 69,536 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 5,699 | $157.86 | $899,644.14 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.64 to $157.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,801 | $157.31 | $755,245.31 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,573 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.64 to $157.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,500 | $30.89 | $200,785.00 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:32 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 327.0981 | $45.27 | $14,807.73 |
DisclosureSEC source: 0001555280-20-000237 · wf-form4_159536351623390.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,044.0586 Underlying: Common Stock · 102.3623 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,185 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 3,885 options granted January 31, 2013 at an exercise price of $26.00 per option and 2,615 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 76,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,800 | $131.65 | $368,620.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.46 to $131.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 7,700 | $131.19 | $1,010,163.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,674 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.43 to $131.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 2,615 | $30.89 | $80,777.35 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,885 | $26.00 | $101,010.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:04 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 839.1061 | $38.93 | $32,666.40 |
DisclosureSEC source: 0001555280-20-000181 · wf-form4_158715745685962.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,716.9605 Underlying: Common Stock · 263.843 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 23:06 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 1,543.0995 | $37.07 | $57,202.70 |
DisclosureSEC source: 0001555280-20-000158 · wf-form4_158586874573869.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,877.8544 Underlying: Common Stock · 486.0455 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000136 · wf-form4_158275215654939.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,685 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 6,500 options granted January 31, 2013 at an exercise price of $26.00 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 3,885 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 3,800 | $138.62 | $526,756.00 |
DisclosureSEC source: 0001555280-20-000136 · wf-form4_158275215654939.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.61 to $138.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 8,125 | $137.85 | $1,120,031.25 |
DisclosureSEC source: 0001555280-20-000136 · wf-form4_158275215654939.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,674 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.27 to $138.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,500 | $26.00 | $169,000.00 |
DisclosureSEC source: 0001555280-20-000136 · wf-form4_158275215654939.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 12,804.9022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · derivative · entry 6 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,804.9022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 8,643.6151 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,237.7037 Underlying: Common Stock · 8,643.6151 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 8,643.6151 RSUs vested on February 14, 2020; 6,909.5267 RSUs will vest on February 13, 2021; 5,172.1770 RSUs will vest on February 12, 2022; and 13,156 RSUs will vest on February 11, 2023. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 8,643.6151 RSUs vested on February 14, 2020; 6,909.5267 RSUs will vest on February 13, 2021; 5,172.1770 RSUs will vest on February 12, 2022; and 13,156 RSUs will vest on February 11, 2023. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 8,643.6151 RSUs vested on February 14, 2020; 6,909.5267 RSUs will vest on February 13, 2021; 5,172.1770 RSUs will vest on February 12, 2022; and 13,156 RSUs will vest on February 11, 2023. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 6,307 | $144.17 | $909,280.19 |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · nonDerivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,299 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 12,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 3,218 | $144.17 | $463,939.06 |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,802 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:56 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 8,643 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000112 · wf-form4_158214934343804.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.